Schedule 13G ownership disclosure

YD BIO LTD CMN

Ordinary Shares, par value of US$0.0001 per share · CUSIP: G98301107

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Ethan Shen

    Shares: 54,345,011.00 · Class: 77.1%

  • YD Biopharma Holding Limited

    Shares: 43,120,858.00 · Class: 61.1%

  • EG Biomed Limited

    Shares: 11,224,153.00 · Class: 15.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-122504
Form type
SCHEDULE 13G
Filer
Shen Ethan PhD
CIK
CIK 2099921
Filed
Dec 16, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub